Krill Products: An Overview of Animal Studies
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Many animal studies have been performed with krill oil (KO) and this review aims to summarize their findings and give insight into the mechanism of action of KO. Animal models that have been used in studies with KO include obesity, depression, myocardial infarction, chronic low-grade and ulcerative inflammation and are described in detail. Moreover, studies with KO in the form of krill powder (KP) and krill protein concentrate (KPC) as a mix of lipids and proteins are mentioned and compared to the effects of KO. In addition, differences in tissue uptake of the long-chain omega-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), when delivered in either phospholipid or triglyceride form, are addressed and the differential impact the delivery form has on gene expression profiles is explained. In our outlook, we try to highlight the potential of KO and KP supplementation in clinical settings and discuss health segments that have a high potential of showing krill product specific health benefits and warrant further clinical investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Distribution, interconversion, and dose response of n-3 fatty acids in humans.
Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
Nguyen, L. N., Ma, D., Shui, G., Wong, P., Cazenave-Gassiot, A., Zhang, X., Wenk, M. R., Goh, E. L. K., & Silver, D. L. (2014) · Nature · doi:10.1038/nature13241 · Cited by 1,048
Sarcopenia and Physical Frailty: Two Sides of the Same Coin
Cesari, M., Landi, F., Vellas, B., Bernabei, R., & Marzetti, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00192 · Cited by 468
Polyunsaturated fatty acid–cholesterol interactions: Domain formation in membranes
Wassall, S. R., & Stillwell, W. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.011 · Cited by 292 · cited 17×
“A substantial amount of studies on EPA and DHA have assessed the health benefits of n-3 PUFAs [15,16] and have found them to be crucial at cellular levels for maintaining membrane homeostasis, as ligands for transcription factors thus influencing gene expression, and for an optimal balance with omega-6 FAs for the for…”
BackgroundInfluentialSchuchardt, J., Schneider, I., Meyer, H., Neubronner, J., von Schacky, C., & Hahn, A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-145 · Cited by 291 · cited 1×
“In some studies, the effects of n-3 PUFAs from KO were more pronounced than the ones observed with FO [44–46].”
ResultOmega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
Hartweg, J., Perera, R., Montori, V. M., Dinneen, S. F., Neil, A. H., & Farmer, A. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003205.pub2 · Cited by 282
The differential effects of EPA and DHA on cardiovascular risk factors
Cottin, S. C., Sanders, T. A., & Hall, W. L. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000061 · Cited by 247 · cited 1×
“Through these means they have the potential to influence regulation of inflammatory response, neurological and psychiatric balance and body composition homeostasis [17–19].”
BackgroundRossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038834 · Cited by 230 · cited 1×
“In studies with Zucker rats, a model for obesity and its related metabolic dysfunctions, KO has been shown to influence EC levels both in peripheral tissues, as well as in the brain [8,23,28].”
BackgroundLiu, L., Bartke, N., Van Daele, H., Lawrence, P., Qin, X., Park, H. G., Kothapalli, K., Windust, A., Bindels, J., Wang, Z., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m045930 · Cited by 117 · cited 3×
“This may be due to the fact that KO contains EPA and DHA mainly in the chemical form of PLs with the attributed increased tissue delivery efficacy [6,7,9].”
BackgroundResultRossi, S., De Chiara, V., Musella, A., Sacchetti, L., Cantarella, C., Castelli, M., Cavasinni, F., Motta, C., Studer, V., Bernardi, G., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064196 · Cited by 82 · cited 1×
“It is worth noting that KO administration did not affect AEA levels and is therefore unlikely to negatively interfere with stress and anxiety symptoms [52].”
Background
Cited by
Stress management in aquaculture: a review of dietary interventions
Ciji, A., & Akhtar, M. S. (2021) · Reviews in Aquaculture · doi:10.1111/raq.12565 · Cited by 265
Xie, D., Gong, M., Wei, W., Jin, J., Wang, X., Wang, X., & Jin, Q. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12427 · Cited by 214
Microalgae as Sources of Omega-3 Polyunsaturated Fatty Acids: Biotechnological Aspects
Barta, D. G., Coman, V., & Vodnar, D. C. (2021) · Algal Research · doi:10.1016/j.algal.2021.102410 · Cited by 178
Berge, R. K., Ramsvik, M. S., Bohov, P., Svardal, A., Nordrehaug, J. E., Rostrup, E., Bruheim, I., & Bjørndal, B. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0162-7 · Cited by 51
“5-2 g/day krill oil significantly reduced plasma TAG [20].”
BackgroundUrsoniu, S., Sahebkar, A., Serban, M.-C., Antal, D., Mikhailidis, D. P., Cicero, A., Athyros, V., Rizzo, M., Rysz, J., & Banach, M. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw063 · Cited by 48
Metadata
- Authors
- Burri, L., & Johnsen, L.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2015-05-07
- Volume
- 7
- Issue
- 5
- Pages
- 3300-3321
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2099552707
- Cited by
- 71
- References
- 11
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.